All Stories

  1. Challenges in diagnosis of sarcoidosis

    Article • Current Opinion in Immunology, December 2025, Elsevier

    Francesco Bonella

  2. Racial, Ethnic, Sex, and Gender Equity for Inclusive Interstitial Lung Disease Research: An Official American Thoracic Society Research Statement

    Article • American Review of Respiratory Disease, December 2025, American Thoracic Society

    Francesco Bonella

  3. Sarcoidosis: A State-Of-The-Art Review

    Article • European Respiratory Journal, November 2025, European Respiratory Society (ERS)

    Francesco Bonella, Natalia V Rivera

  4. Design of a Phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosis

    Article • ERJ Open Research, November 2025, European Respiratory Society (ERS)

    Francesco Bonella

  5. Circulating biomarkers in subjects with progressive pulmonary fibrosis: data from the INBUILD trial

    Article • ERJ Open Research, September 2025, European Respiratory Society (ERS)

    Francesco Bonella

  6. Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2025, New England Journal of Medicine (NEJM/MMS)

    Francesco Bonella

  7. Summary for clinicians: ERS guidelines on pulmonary alveolar proteinosis

    Article • Breathe, April 2025, European Respiratory Society (ERS)

    Dr Tiago M Alfaro, Francesco Bonella

  8. Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registry

    Article • ERJ Open Research, February 2025, European Respiratory Society (ERS)

    Francesco Bonella

  9. The role of heat shock protein 90 in idiopathic pulmonary fibrosis: state of the art

    Article • European Respiratory Review, January 2025, European Respiratory Society (ERS)

    Francesco Bonella

  10. European Respiratory Society guidelines for the Diagnosis and Management of Pulmonary Alveolar Proteinosis

    Article • European Respiratory Journal, August 2024, European Respiratory Society (ERS)

    Dr Tiago M Alfaro, Francesco Bonella, Alexander Mathioudakis

  11. Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis

    Article • European Respiratory Review, July 2024, European Respiratory Society (ERS)

    Francesco Bonella

  12. Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

    Article • American Review of Respiratory Disease, March 2024, American Thoracic Society

    Francesco Bonella

  13. Kidney manifestations of sarcoidosis

    Article • Journal of Autoimmunity, March 2024, Elsevier

    Francesco Bonella

  14. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival

    Article • CHEST Journal, January 2024, Elsevier

    Francesco Bonella

  15. Will inhalational GM-CSF replace whole lung lavage as a treatment for autoimmune pulmonary alveolar proteinosis? Many pole positions, not yet the final winner

    Article • European Respiratory Journal, January 2024, European Respiratory Society (ERS)

    Francesco Bonella

  16. Pulmonale Alveolarproteinose (PAP)

    Article • January 2024, Thieme Publishing Group

    Francesco Bonella

  17. Pulmonale alveoläre Mikrolithiasis (PAM)

    Article • January 2024, Thieme Publishing Group

    Francesco Bonella

  18. Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis

    Article • Drugs, October 2023, Springer Science + Business Media

    Francesco Bonella

  19. Serum KL-6 as a Candidate Predictor of Outcome in Patients with SARS-CoV-2 Pneumonia

    Article • Journal of Clinical Medicine, October 2023, MDPI AG

    Francesco Bonella

  20. Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial

    Article • European Respiratory Journal, October 2023, European Respiratory Society (ERS)

    MD Pilar Rivera Ortega, Francesco Bonella

  21. Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease

    Article • Journal of Clinical Medicine, February 2023, MDPI AG

    Francesco Bonella

  22. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis

    Article • Respirology, December 2022, Wiley

    Francesco Bonella

  23. European Respiratory Society Statement on Familial Pulmonary Fibrosis

    Article • European Respiratory Journal, December 2022, European Respiratory Society (ERS)

    Francesco Bonella

  24. Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe

    Article • Respirology, September 2022, Wiley

    Francesco Bonella

  25. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective

    Article • American Review of Respiratory Disease, August 2022, American Thoracic Society

    Francesco Bonella

  26. COVID-19 in patients with Pulmonary Alveolar Proteinosis A European multicenter study

    Article • ERJ Open Research, July 2022, European Respiratory Society (ERS)

    Francesco Bonella

  27. Genetic testing in interstitial lung disease: An international survey

    Article • Respirology, June 2022, Wiley

    Francesco Bonella

  28. Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases

    Article • Advances in Therapy, May 2022, Springer Science + Business Media

    Francesco Bonella

  29. Targeted therapy for pulmonary alveolar proteinosis: the time is now

    Article • European Respiratory Journal, April 2022, European Respiratory Society (ERS)

    francesco bonella, Francesco Bonella

  30. Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases

    Article • Respirology, February 2022, Wiley

    Francesco Bonella

  31. Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?

    Article • ERJ Open Research, November 2021, European Respiratory Society (ERS)

    marlies wijsenbeek , Francesco Bonella

  32. Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden

    Article • Respirology, October 2021, Wiley

    Francesco Bonella

  33. Modified GAP index by including serum KL-6 to assess risk of disease progression in patients with interstitial lung diseases (ILD): preliminary results from the VAMOS study

    Article • September 2021, European Respiratory Society (ERS)

    Francesco Bonella

  34. Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF

    Article • Orphanet Journal of Rare Diseases, February 2021, Springer Science + Business Media

    Francesco Bonella

  35. Chest radiography or computed tomography for COVID-19 pneumonia? Comparative study in a simulated triage setting

    Article • European Respiratory Journal, February 2021, European Respiratory Society (ERS)

    Francesco Bonella

  36. Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF

    Article • February 2021, Research Square

    Francesco Bonella

  37. S2K Guideline for Diagnosis of Idiopathic Pulmonary Fibrosis

    Article • Respiration, January 2021, Karger Publishers

    Francesco Bonella

  38. Potential Clinical Utility of MUC5B und TOLLIP Single Nucleotide Polymorphisms (SNPs) in the Management of Patients with IPF

    Article • December 2020, Research Square

    Francesco Bonella

  39. Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2020, New England Journal of Medicine (NEJM/MMS)

    Francesco Bonella

  40. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

    Article • Annals of the Rheumatic Diseases, October 2020, BMJ

    Francesco Bonella

  41. Ganzlungenlavage bei pulmonaler Alveolarproteinose – Schritt für Schritt

    Article • Pneumologie, October 2020, Thieme Publishing Group

    Francesco Bonella

  42. Clinical burden of idiopathic pulmonary fibrosis (IPF): physician and patient perception

    Article • September 2020, European Respiratory Society (ERS)

    Francesco Bonella

  43. Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment

    Article • Immunobiology, September 2020, Elsevier

    Francesco Bonella

  44. When the Game Changes

    Article • CHEST Journal, September 2020, Elsevier

    Francesco Bonella

  45. Hypersensitivity pneumonitis

    Article • Nature Reviews Disease Primers, August 2020, Springer Science + Business Media

    Francesco Bonella

  46. The perpetual enigma of bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: is it of diagnostic value?

    Article • European Respiratory Journal, August 2020, European Respiratory Society (ERS)

    Francesco Bonella

  47. Looking into the future of sarcoidosis: what is next for treatment?

    Article • Current Opinion in Pulmonary Medicine, July 2020, Wolters Kluwer Health

    Francesco Bonella

  48. Shedding light on developmental drugs for idiopathic pulmonary fibrosis

    Article • Expert Opinion on Investigational Drugs, June 2020, Taylor & Francis

    Francesco Bonella

  49. Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19

    Article • Journal of Medical Virology, June 2020, Wiley

    Francesco Bonella

  50. A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis

    Article • CHEST Journal, June 2020, Elsevier

    Francesco Bonella

  51. Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review

    Article • Biomarkers in Medicine, June 2020, Future Medicine

    Francesco Bonella

  52. Efficacy, safety, and tolerability of combined pirfenidone and N-acetylcysteine therapy: a systematic review and meta-analysis

    Article • BMC Pulmonary Medicine, May 2020, Springer Science + Business Media

    Francesco Bonella

  53. Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis

    Article • European Journal of Cancer, May 2020, Elsevier

    Francesco Bonella

  54. S2K-Leitlinie zur Diagnostik der idiopathischen Lungenfibrose

    Article • Pneumologie, May 2020, Thieme Publishing Group

    Francesco Bonella

  55. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

    Article • The Lancet Respiratory Medicine, May 2020, Elsevier

    Francesco Bonella, Evans Fernández Pérez

  56. Genotype in MUC5B-Promoter Polymorphism and Chronic Lung Allograft Dysfunction (CLAD) in a German Cohort: Preliminary Results

    Article • The Journal of Heart and Lung Transplantation, April 2020, Elsevier

    Francesco Bonella

  57. S2K-Leitlinie zur Diagnostik der idiopathischen Lungenfibrose

    Article • Pneumologie, March 2020, Thieme Publishing Group

    Francesco Bonella

  58. Therapie von Komplikationen und nichtpharmakologisches Management der idiopathischen pulmonalen Fibrose

    Article • Der Pneumologe, March 2020, Springer Science + Business Media

    Francesco Bonella

  59. Azathioprine for Connective Tissue Disease-Associated Interstitial Lung Disease

    Article • Respiration, January 2020, Karger Publishers

    Francesco Bonella

  60. Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis: German and Japanese Cohort Study

    Article • Journal of Clinical Medicine, November 2019, MDPI AG

    Francesco Bonella

  61. Therapie der systemischen Sklerose-assoziierten interstitiellen Lungenerkrankung

    Article • Zeitschrift für Rheumatologie, November 2019, Springer Science + Business Media

    Francesco Bonella

  62. Quantitative Lipidomics in Pulmonary Alveolar Proteinosis

    Article • American Review of Respiratory Disease, October 2019, American Thoracic Society

    Matthias Griese, Francesco Bonella

  63. Shaping the future of an ultra-rare disease

    Article • Current Opinion in Pulmonary Medicine, September 2019, Wolters Kluwer Health

    Associate Professor Cormac McCarthy, Francesco Bonella

  64. Editorial introductions

    Article • Current Opinion in Pulmonary Medicine, September 2019, Wolters Kluwer Health

    Francesco Bonella

  65. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis

    Article • American Review of Respiratory Disease, July 2019, American Thoracic Society

    Francesco Bonella

  66. Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials

    Article • European Respiratory Journal, July 2019, European Respiratory Society (ERS)

    Francesco Bonella

  67. Correction to: The Burden of Sarcoidosis Symptoms from a Patient Perspective

    Article • Lung, April 2019, Springer Science + Business Media

    Francesco Bonella

  68. Pulmonary alveolar proteinosis

    Article • Nature Reviews Disease Primers, March 2019, Springer Science + Business Media

    Associate Professor Cormac McCarthy, Francesco Bonella

  69. The Burden of Sarcoidosis Symptoms from a Patient Perspective

    Article • Lung, February 2019, Springer Science + Business Media

    Francesco Bonella

  70. Changes in serum KL-6 levels are associated with the development of chronic lung allograft dysfunction in lung transplant recipients

    Article • Transplant Immunology, February 2019, Elsevier

    Francesco Bonella

  71. Erratum zu: Differenzialdiagnose interstitieller Lungenerkrankungen – „Interstitial pneumonia with autoimmune features“ (IPAF)

    Article • Der Pneumologe, January 2019, Springer Science + Business Media

    Francesco Bonella

  72. Utility of Anti-DSF70 Antibodies to Predict Connective Tissue Disease in Patients Originally Presenting with Idiopathic Interstitial Pneumonia

    Article • Respiration, January 2019, Karger Publishers

    Francesco Bonella

  73. Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study

    Article • The Journal of Rheumatology, November 2018, The Journal of Rheumatology

    Francesco Bonella

  74. Differenzialdiagnose interstitieller Lungenerkrankungen

    Article • Der Pneumologe, August 2018, Springer Science + Business Media

    Francesco Bonella

  75. Die „Rheumalunge“ in der Computertomographie: radiologische Manifestationen der rheumatoiden Arthritis

    Article • Der Pneumologe, August 2018, Springer Science + Business Media

    Francesco Bonella

  76. The Management of Patients With Idiopathic Pulmonary Fibrosis

    Article • Frontiers in Medicine, July 2018, Frontiers

    Francesco Bonella

  77. Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis. An International Modified Delphi Survey

    Article • American Review of Respiratory Disease, April 2018, American Thoracic Society

    Francesco Bonella, Evans Fernández Pérez

  78. Patientenfragebogen zur Erfassung der Ursachen interstitieller und seltener Lungenerkrankungen – klinische Sektion der DGP

    Article • Pneumologie, February 2018, Thieme Publishing Group

    Francesco Bonella

  79. Patients with IPF and lung cancer: diagnosis and management

    Article • The Lancet Respiratory Medicine, February 2018, Elsevier

    Francesco Bonella

  80. German Guideline for Idiopathic Pulmonary Fibrosis – Update on Pharmacological Therapies 2017

    Article • Pneumologie, January 2018, Thieme Publishing Group

    Francesco Bonella

  81. Phenotypes of organ involvement in sarcoidosis

    Article • European Respiratory Journal, January 2018, European Respiratory Society (ERS)

    Joachim Müller-Quernheim, Francesco Bonella

  82. Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Uncertainties and Controversies

    Article • Respiration, January 2018, Karger Publishers

    Francesco Bonella

  83. Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis

    Article • Respiration, January 2018, Karger Publishers

    Francesco Bonella

  84. Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis

    Article • Respiration, January 2018, Karger Publishers

    Francesco Bonella

  85. Serum YKL-40 in workers at an indium-tin oxide production facility - Reply

    Article • Respirology, December 2017, Wiley

    Francesco Bonella

  86. Idiopathic pleuroparenchymal fibroelastosis (PPFE) – A case study of a rare entity

    Article • Revista Portuguesa de Pneumologia (English Edition), November 2017, Elsevier

    Francesco Bonella

  87. Therapeutic targets in idiopathic pulmonary fibrosis

    Article • Respiratory Medicine, October 2017, Elsevier

    Francesco Bonella

  88. Unmet needs in the treatment of idiopathic pulmonary fibrosis―insights from patient chart review in five European countries

    Article • BMC Pulmonary Medicine, September 2017, Springer Science + Business Media

    Francesco Bonella

  89. Differential diagnosis of granulomatous lung disease: clues and pitfalls

    Article • European Respiratory Review, August 2017, European Respiratory Society (ERS)

    francesco bonella, Francesco Bonella

  90. Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis

    Article • Respirology, May 2017, Wiley

    Matthias Griese, Shinichiro Ohshimo, Francesco Bonella

  91. S2k-Leitlinie Idiopathische Lungenfibrose – Update zur medikamentösen Therapie 2017

    Article • Pneumologie, May 2017, Thieme Publishing Group

    Francesco Bonella

  92. FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosis

    Article • Respiratory Medicine, February 2017, Elsevier

    Francesco Bonella

  93. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone

    Article • Respiration, January 2017, Karger Publishers

    Francesco Bonella

  94. Coagulation factor XII regulates inflammatory responses in human lungs

    Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

    Francesco Bonella

  95. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis

    Article • European Respiratory Journal, November 2016, European Respiratory Society (ERS)

    francesco bonella, Francesco Bonella

  96. Daily Home Spirometry: A New Milestone in the Field of Pulmonary Fibrosis

    Article • American Review of Respiratory Disease, October 2016, American Thoracic Society

    Francesco Bonella

  97. Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis

    Article • Thorax, October 2016, BMJ

    Francesco Bonella

  98. Deutschsprachige Validierung des „Kingʼs Brief Interstitial Lung Disease (K-BILD)“ Lebensqualitätsfragebogens für interstitielle Lungenerkrankungen

    Article • Pneumologie, September 2016, Thieme Publishing Group

    Francesco Bonella

  99. New insights on patient-reported outcome measures in idiopathic pulmonary fibrosis

    Article • Current Opinion in Pulmonary Medicine, September 2016, Wolters Kluwer Health

    Mirjam J.G. van Manen, Francesco Bonella

  100. Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures

    Article • Orphanet Journal of Rare Diseases, August 2016, Springer Science + Business Media

    Francesco Bonella

  101. Epidemiologie und klinisches Erscheinungsbild der Sarkoidose

    Article • Klinische Monatsblätter für Augenheilkunde, July 2016, Thieme Publishing Group

    Francesco Bonella

  102. A Global Survey on Whole Lung Lavage in Pulmonary Alveolar Proteinosis

    Article • CHEST Journal, July 2016, Elsevier

    Francesco Bonella

  103. European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity

    Article • European Respiratory Journal, June 2016, European Respiratory Society (ERS)

    francesco bonella, Francesco Bonella

  104. MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis

    Article • Orphanet Journal of Rare Diseases, April 2016, Springer Science + Business Media

    Francesco Bonella

  105. How to handle IPF – the new Portuguese consensus document

    Article • Revista Portuguesa de Pneumologia (English Edition), March 2016, Elsevier

    Francesco Bonella

  106. An Important Step Forward, but Still a Way to Go

    Article • American Review of Respiratory Disease, February 2016, American Thoracic Society

    Francesco Bonella

  107. Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis

    Article • Respiration, January 2016, Karger Publishers

    Francesco Bonella

  108. Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib

    Article • Drug Design Development and Therapy, December 2015, Dove Medical Press

    francesco bonella, Francesco Bonella

  109. Pulmonary alveolar proteinosis in a cat

    Article • BMC Veterinary Research, December 2015, Springer Science + Business Media

    Francesco Bonella

  110. European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers

    Article • European Respiratory Journal, November 2015, European Respiratory Society (ERS)

    francesco bonella, Francesco Bonella

  111. Pulmonale Alveolarproteinose

    Article • Der Pneumologe, October 2015, Springer Science + Business Media

    Francesco Bonella

  112. Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis

    Article • September 2015, Springer Science + Business Media

    Francesco Bonella

  113. New guideline on treatment of idiopathic pulmonary fibrosis

    Article • The Lancet Respiratory Medicine, September 2015, Elsevier

    Toby Maher, Francesco Bonella

  114. GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders

    Article • BMC Pulmonary Medicine, August 2015, Springer Science + Business Media

    Francesco Bonella

  115. Positionspapier zur Bedeutung der forcierten Vitalkapazität für Patienten mit idiopathischer Lungenfibrose (IPF)

    Article • Pneumologie, July 2015, Thieme Publishing Group

    Francesco Bonella

  116. Facts and promises on lung biomarkers in interstitial lung diseases

    Article • Expert Review of Respiratory Medicine, July 2015, Taylor & Francis

    Francesco Bonella

  117. Diagnosis of Sarcoidosis

    Article • Clinical Reviews in Allergy & Immunology, March 2015, Springer Science + Business Media

    Francesco Bonella

  118. Update on therapeutic management of idiopathic pulmonary fibrosis

    Article • Therapeutics and Clinical Risk Management, March 2015, Taylor & Francis

    Professor Paolo Spagnolo, francesco bonella, Francesco Bonella

  119. Extracellular 20S proteasome in BAL and serum of patients with alveolar proteinosis

    Article • Immunobiology, March 2015, Elsevier

    Francesco Bonella

  120. MUC5Bpromoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis

    Article • Respirology, January 2015, Wiley

    Francesco Bonella

  121. Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Toby Maher, Francesco Bonella

  122. Alveolar and intraparenchymal proteasome in sarcoidosis

    Article • Respiratory Medicine, October 2014, Elsevier

    Francesco Bonella

  123. Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?

    Article • European Respiratory Review, August 2014, European Respiratory Society (ERS)

    Francesco Bonella

  124. Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis

    Article • Respiratory Medicine, July 2014, Elsevier

    Francesco Bonella

  125. Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease

    Article • Seminars in Respiratory and Critical Care Medicine, March 2014, Thieme Publishing Group

    Francesco Bonella

  126. Interstitial lung disease

    Article • European Respiratory Review, February 2014, European Respiratory Society (ERS)

    Francesco Bonella

  127. Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPDgene polymorphisms

    Article • BMC Medical Genetics, January 2014, Springer Science + Business Media

    Francesco Bonella

  128. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases

    Article • Respiratory Medicine, September 2013, Elsevier

    Francesco Bonella

  129. The Ambitious Goal of Validating Prognostic Biomarkers for Systemic Sclerosis-related Interstitial Lung Disease

    Article • The Journal of Rheumatology, July 2013, The Journal of Rheumatology

    Francesco Bonella

  130. Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia

    Article • Immunobiology, June 2013, Elsevier

    Francesco Bonella

  131. Klinische Erfahrungen mit Pirfenidon in der Therapie der idiopathischen Lungenfibrose

    Article • DMW - Deutsche Medizinische Wochenschrift, March 2013, Thieme Publishing Group

    Francesco Bonella

  132. Sarkoidose

    Article • Der Pneumologe, March 2013, Springer Science + Business Media

    Francesco Bonella

  133. Klinische Erfahrungen mit Pirfenidon in der Therapie der idiopathischen Lungenfibrose

    Article • DMW - Deutsche Medizinische Wochenschrift, February 2013, Thieme Publishing Group

    Francesco Bonella

  134. Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis

    Article • Orphanet Journal of Rare Diseases, January 2013, Springer Science + Business Media

    Francesco Bonella

  135. Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels

    Article • Respiratory Medicine, December 2012, Elsevier

    Francesco Bonella

  136. Diagnostic approach to interstitial pneumonias in a single centre: report on 88 cases

    Article • Diagnostic Pathology, November 2012, Springer Science + Business Media

    Francesco Bonella

  137. Hypersensitivity Pneumonitis

    Article • Immunology and Allergy Clinics of North America, November 2012, Elsevier

    Francesco Bonella

  138. Wash-out kinetics and efficacy of a modified lavage technique for alveolar proteinosis

    Article • European Respiratory Journal, April 2012, European Respiratory Society (ERS)

    Francesco Bonella

  139. Chronic Hypersensitivity Pneumonitis

    Article • Clinics in Chest Medicine, March 2012, Elsevier

    Francesco Bonella

  140. KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome

    Article • Orphanet Journal of Rare Diseases, January 2012, Springer Science + Business Media

    Francesco Bonella

  141. Self-reported asthma and respiratory symptoms among Italian amateur athletes

    Article • European Journal of Sport Science, January 2012, Taylor & Francis

    Francesco Bonella

  142. Whole-Lung Lavage: A Successful Treatment for Restoring Acinar Ventilation Distribution in Primary Acquired Pulmonary Alveolar Proteinosis

    Article • Respiration, January 2012, Karger Publishers

    Francesco Bonella

  143. Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation

    Article • The Journal of Heart and Lung Transplantation, December 2011, Elsevier

    Francesco Bonella

  144. Pulmonary alveolar proteinosis: New insights from a single-center cohort of 70 patients

    Article • Respiratory Medicine, December 2011, Elsevier

    Francesco Bonella

  145. Therapie der Lungenfibrose

    Article • Der Internist, November 2011, Springer Science + Business Media

    Francesco Bonella

  146. Diagnostic Modalities in Sarcoidosis: BAL, EBUS, and PET

    Article • Seminars in Respiratory and Critical Care Medicine, July 2010, Thieme Publishing Group

    Francesco Bonella

  147. A female soccer player with recurrent haemoptysis and iron deficiency anaemia: idiopathic pulmonary haemosiderosis (IPH)--case report and literature review

    Article • BMJ Case Reports, January 2010, BMJ

    Francesco Bonella

  148. Angiogenic and Angiostatic Chemokines in Idiopathic Pulmonary Fibrosis and Granulomatous Lung Disease

    Article • Respiration, January 2010, Karger Publishers

    Francesco Bonella

  149. To BAL or Not to BAL: Is This a Problem in Diagnosing IPF?

    Article • American Review of Respiratory Disease, August 2009, American Thoracic Society

    Francesco Bonella

  150. Die bronchoalveoläre Lavage aus klinischer Sicht

    Article • Der Pneumologe, June 2009, Springer Science + Business Media

    Francesco Bonella

  151. Significance of Bronchoalveolar Lavage for the Diagnosis of Idiopathic Pulmonary Fibrosis

    Article • American Review of Respiratory Disease, June 2009, American Thoracic Society

    Francesco Bonella

  152. Acid reflux into the oesophagus does not influence exercise-induced airway narrowing in bronchial asthma

    Article • British Journal of Sports Medicine, October 2008, BMJ

    Francesco Bonella

  153. Bronchoalveolar Lavage in Other Interstitial Lung Diseases

    Article • Seminars in Respiratory and Critical Care Medicine, October 2007, Thieme Publishing Group

    Francesco Bonella

  154. Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal reflux

    Article • Scandinavian Journal of Gastroenterology, January 2007, Taylor & Francis

    Francesco Bonella

  155. Biomarkers

    Article • European Respiratory Society (ERS)

    Francesco Bonella